ALEXANDRIA, VA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES, founded in 1950, is a mid-sized nonprofit in the Diseases & Disorders sector that reported $18.3M in total revenue in fiscal year 2024. Revenue grew 15% year-over-year, indicating healthy expansion. Expenses of $20.3M exceeded revenue, resulting in a 11% operating deficit.
TO ADVANCE AND DISSEMINATE THE SCIENCE AND PRACTICE OF HEPATOLOGY, AND TO PROMOTE LIVER HEALTH AND QUALITY PATIENT CARE.
MEETINGS AND EDUCATION, INCLUDING THE LIVER MEETING: AASLD'S DYNAMIC EDUCATIONAL PROGRAMS PROVIDE HEALTHCARE PROFESSIONALS CUTTING-EDGE ADVANCEMENTS IN SCIENCE AND INNOVATIVE NEW TECHNIQUES TO...
MEETINGS AND EDUCATION, INCLUDING THE LIVER MEETING: AASLD'S DYNAMIC EDUCATIONAL PROGRAMS PROVIDE HEALTHCARE PROFESSIONALS CUTTING-EDGE ADVANCEMENTS IN SCIENCE AND INNOVATIVE NEW TECHNIQUES TO ADVANCE HEPATOLOGY TRAINING AND PROFESSIONAL DEVELOPMENT THROUGH IMMERSIVE FACE-TO-FACE EVENTS AND ROBUST ONLINE LEARNING PLATFORMS. THESE INITIATIVES FOSTER THE EXCHANGE OF GROUNDBREAKING RESEARCH, ELEVATE PATIENT CARE, AND SPARK NEW DISCOVERIES IN LIVER DISEASE MANAGEMENT. THE LIVER MEETING, AASLD'S PREMIER ANNUAL EVENT, IS A GLOBAL CORNERSTONE FOR THE FIELD OF HEPATOLOGY, SHOWCASING TRANSFORMATIVE RESEARCH AND TREATMENT OUTCOMES. ATTENDEES ENGAGE IN PLENARY AND PARALLEL SESSIONS, POSTER PRESENTATIONS, STATE-OF-THE-ART LECTURES, MEET-THE-EXPERT SESSIONS, SPECIALTY COURSES, AND SPECIAL INTEREST GROUP PROGRAMMING FOSTERING COLLABORATION AND KNOWLEDGE-SHARING AMONG LEADING EXPERTS AND PRACTITIONERS. ADDITIONALLY, AASLD HOSTS FOCUSED STAND-ALONE EVENTS LIKE THE EMERGING TOPIC CONFERENCES, CO-SPONSORS DIGESTIVE DISEASE WEEK, AND PARTNERS WITH DOMESTIC AND INTERNATIONAL MEDICAL SOCIETIES, GOVERNMENT ENTITIES, AND NONPROFIT ORGANIZATIONS TO DELIVER IMPACTFUL EDUCATIONAL PROGRAMMING IN HEPATOLOGY.AASLD'S ONLINE LEARNING ECOSYSTEM, ANCHORED BY LIVERLEARNING, THE OFFICIAL E-LEARNING PORTAL, OFFERS ON-DEMAND WEBINARS ORGANIZED BY SPECIAL INTEREST GROUPS, PROVIDING IN-DEPTH EXPLORATION OF SPECIALIZED TOPICS. LIVERLEARNING SERVES AS A COMPREHENSIVE DIGITAL REPOSITORY, HOUSING CONTENT FROM AASLD MEETINGS, PRACTICE GUIDELINES, SLIDE COMPILATIONS, AND COURSE HANDOUTS, ENABLING HEALTHCARE PROVIDERS TO SEAMLESSLY APPLY THE LATEST MEDICAL KNOWLEDGE TO CLINICAL PRACTICE. THE ORGANIZATION ALSO SUPPORTS ONLINE CONTENT THROUGH SIGNAL PLATFORM SPECIFICALLY DESIGNED FOR OUR SPECIAL INTEREST GROUPS. AASLD IS ACCREDITED BY THE ACCREDITATION COUNCIL FOR CONTINUING MEDICAL EDUCATION (ACCME) TO PROVIDE AMA PRA CATEGORY 1 CREDITS FOR PHYSICIANS. ADDITIONALLY, AASLD OFFERS MAINTENANCE OF CERTIFICATION (MOC) POINTS, AWARDED UPON SUCCESSFUL COMPLETION OF DESIGNATED CME PROGRAMS, WITH MOC ULTIMATELY GRANTED BY THE AMERICAN BOARD OF INTERNAL MEDICINE OR AMERICAN BOARD OF PEDIATRICS.
PUBLICATIONS: AASLD'S JOURNALS, HEPATOLOGY, LIVER TRANSPLANTATION, AND HEPATOLOGY COMMUNICATIONS DELIVER PEER-REVIEWED, HIGH-IMPACT RESEARCH ON LIVER AND BILIARY TRACT DISEASES, SETTING THE STANDARD...
PUBLICATIONS: AASLD'S JOURNALS, HEPATOLOGY, LIVER TRANSPLANTATION, AND HEPATOLOGY COMMUNICATIONS DELIVER PEER-REVIEWED, HIGH-IMPACT RESEARCH ON LIVER AND BILIARY TRACT DISEASES, SETTING THE STANDARD FOR SCIENTIFIC EXCELLENCE IN THE FIELD. AASLD'S FLAGSHIP JOURNAL, HEPATOLOGY, PUBLISHES ORIGINAL, PEER-REVIEWED ARTICLES CONCERNING ALL ASPECTS OF LIVER STRUCTURE, FUNCTION AND DISEASE. EACH MONTH, THE DISTINGUISHED EDITORIAL BOARD MONITORS AND SELECTS ONLY THE BEST ARTICLES ON SUBJECTS SUCH AS IMMUNOLOGY, CHRONIC HEPATITIS, VIRAL HEPATITIS, CIRRHOSIS, GENETIC AND METABOLIC LIVER DISEASES AND THEIR COMPLICATIONS, LIVER CANCER, AND DRUG METABOLISM. LIVER TRANSPLANTATION PUBLISHES CUTTING EDGE SCIENTIFIC BREAKTRLIVER TRANSPLANTATION, A SPECIALIZED JOURNAL, PROVIDES AUTHORITATIVE INSIGHTS INTO THE LATEST ADVANCEMENTS IN LIVER TRANSPLANTATION. HEPATOLOGY COMMUNICATIONS, AN OPEN-ACCESS, PEER-REVIEWED JOURNAL, ENSURES RAPID DISSEMINATION OF HIGH-QUALITY BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH, AMPLIFYING AASLD'S COMMITMENT TO ADVANCING HEPATOLOGY WORLDWIDE.PROFESSIONAL RELATIONS: AASLD'S PROFESSIONAL RELATIONS INITIATIVES STRENGTHEN THE HEPATOLOGY COMMUNITY THROUGH:1. AASLD PRACTICE GUIDELINES: EVIDENCE-BASED RECOMMENDATIONS GROUNDED IN RIGOROUS SCIENTIFIC RESEARCH TO GUIDE PRACTITIONERS AND PATIENTS IN MAKING INFORMED HEALTHCARE DECISIONS FOR SPECIFIC CLINICAL SCENARIOS.2. PRACTICE METRICS COMMITTEE: THIS COMMITTEE DEVELOPS AND REFINES PERFORMANCE MEASURES TO EVALUATE AND ENHANCE THE QUALITY OF CARE FOR LIVER DISEASE PATIENTS FROM BOTH PROVIDER AND PATIENT PERSPECTIVES. IT DRIVES QUALITY IMPROVEMENT INITIATIVES, SUCH AS THE CIRRHOSIS QUALITY COLLABORATIVE (CQC), AND COLLABORATES WITH OTHER AASLD COMMITTEES AND SPECIALTY SOCIETIES TO ADVANCE PATIENT SAFETY AND CARE STANDARDS.3. RELATED SOCIETY COLLABORATIONS: AASLD FOSTERS PARTNERSHIPS WITH DOMESTIC AND INTERNATIONAL MEDICAL SOCIETIES TO ADVANCE HEPATOLOGY THROUGH SHARED PROGRAMS AND ACTIVITIES. MEMBER REPRESENTATIVES ADVOCATE FOR AASLD'S MISSION AT GLOBAL MEETINGS, CREATING PROGRAMS THAT RESONATE WITH AUDIENCES INTERESTED IN MUTUAL TOPICS.4. PATIENT ENGAGEMENT: AASLD IS DEDICATED TO DEEPENING PATIENT CONNECTIONS BY INCREASING PATIENT REPRESENTATION IN ITS ACTIVITIES, ENHANCING ACCESS TO EXPERT RESOURCES, AND BUILDING ROBUST ADVOCACY PARTNERSHIPS TO AMPLIFY THE PATIENT VOICE IN HEPATOLOGY.CLINICAL AND PUBLIC POLICY: AASLD'S PUBLIC POLICY COMMITTEE LEADS A ROBUST ADVOCACY PROGRAM, HOSTING TWO KEY ANNUAL EVENTS: - LIVER CAPITOL HILL DAY: IN PARTNERSHIP WITH PATIENT ADVOCACY ORGANIZATIONS, AASLD EDUCATES CONGRESSIONAL LEGISLATORS AND STAFF ON CRITICAL ISSUES IN LIVER DISEASE RESEARCH AND PATIENT CARE, DRIVING POLICY CHANGE.- FEDERAL AGENCY DAY: AASLD ENGAGES WITH FEDERAL AGENCY PARTNERS TO ALIGN THE SCIENTIFIC COMMUNITY WITH FEDERAL RESEARCH PRIORITIES, FOSTERING COLLABORATION AND INNOVATION.AASLD ENSURES ITS MEMBERS STAY INFORMED ON LEGISLATIVE AND AGENCY DECISIONS IMPACTING HEPATOLOGY, ENCOURAGING ACTIVE PARTICIPATION IN PUBLIC POLICY ADVOCACY.
MEMBERSHIP & MENTORSHIP: AASLD'S VIBRANT MEMBERSHIP OF OVER 7,000 PROFESSIONALSSPANNING PHYSICIANS, SCIENTISTS, HEPATOLOGISTS, SURGEONS, PATHOLOGISTS, STUDENTS, AND ALLIED HEALTH EXPERTSDRIVES...
MEMBERSHIP & MENTORSHIP: AASLD'S VIBRANT MEMBERSHIP OF OVER 7,000 PROFESSIONALSSPANNING PHYSICIANS, SCIENTISTS, HEPATOLOGISTS, SURGEONS, PATHOLOGISTS, STUDENTS, AND ALLIED HEALTH EXPERTSDRIVES HEPATOBILIARY RESEARCH AND PATIENT CARE WORLDWIDE. THE AASLD MENTORSHIP PROGRAM INSPIRES AND NURTURES THE NEXT GENERATION OF HEPATOLOGISTS BY PAIRING MEDICAL, SURGICAL, AND PEDIATRIC RESIDENTS, FELLOWS, AND EARLY-CAREER PROFESSIONALS WITH SEASONED MENTORS. THIS PROGRAM ENSURES A LEGACY OF SKILLED, KNOWLEDGEABLE HEPATOLOGISTS DEDICATED TO ACADEMIC MEDICINE AND PATIENT CARE.WEBSITE: AASLD'S WEBSITES (WWW.AASLD.ORG AND HCVGUIDELINES.ORG) SERVE AS A VITAL HUB FOR MEMBERS, SCIENTISTS, PHYSICIANS, ALLIED HEALTH PROFESSIONALS, AND THE PUBLIC, OFFERING SEAMLESS ACCESS TO CUTTING-EDGE HEPATOLOGY RESOURCES. WITH OVER 2.1 MILLION ANNUAL VISITORS, THE SITE FACILITATES EXPLORATION OF RESEARCH, EDUCATIONAL OFFERINGS, AND PROFESSIONAL OPPORTUNITIES IN HEPATOLOGY.COMMUNICATIONSAASLD KEEPS ITS COMMUNITY INFORMED THROUGH THE BIWEEKLY AASLD E-NEWS, DELIVERING UPDATES ON RESEARCH, MILESTONES, AND POLICY DEVELOPMENTS TO MEMBERS. THE ASSOCIATION ALSO AMPLIFIES ITS IMPACT THROUGH STRATEGIC MEDIA RELATIONS, SPOTLIGHTING GROUNDBREAKING RESEARCH FROM THE LIVER MEETING AND ADVOCATING FOR ADVANCES IN LIVER DISEASE TREATMENT AND PATIENT CARE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $18,281,444 | $15,925,326 | +0.1% |
| Expenses | $20,311,953 | $18,577,313 | +0.1% |
| Net Income | $-2,030,509 | $-2,651,987 | -0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| GRACE L SU | PRESIDENT | 5.00 |
Officer
Director
|
$75,000 | $0 | $75,000 |
| TAMAR TADDEI | TREASURER | 5.00 |
Officer
Director
|
$30,000 | $0 | $30,000 |
| SAUL J KARPEN | PRESIDENT-ELECT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| W RAY KIM | PAST PRESIDENT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| JANICE JOU | SECRETARY | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| MICHAEL R LUCEY | SR. COUNCILOR | 5.00 |
Director
|
$0 | $0 | $0 |
| NANCY REAU | COUNCILOR | 5.00 |
Director
|
$0 | $0 | $0 |
| ROTONYA MCCANTS CARR | COUNCILOR | 5.00 |
Director
|
$0 | $0 | $0 |
| OREN FIX | COUNCILOR AT LARGE | 5.00 |
Director
|
$0 | $0 | $0 |
| ANJI WALL | COUNCILOR AT LARGE | 5.00 |
Director
|
$0 | $0 | $0 |
| HARMET MALHI | COUNCILOR AT LARGE | 5.00 |
Director
|
$0 | $0 | $0 |
| MATTHEW D'UVA | CHIEF EXECUTIVE OFFICER | 43.00 |
Officer
|
$637,833 | $109,073 | $746,906 |
| JULIE DEAL END 013125 | AASLD DEP. EXEC. DIR./FDN | 21.00 |
Officer
|
$287,813 | $20,815 | $308,628 |
| MUKARAB ISLAM | VP, FINANCE AND ADMINISTRATION | 39.00 |
Officer
|
$196,100 | $36,139 | $232,239 |
| MARJORIE BYNUM | CHIEF OF STAFF | 39.00 |
Key Emp
|
$254,953 | $38,363 | $293,316 |
| JESSICA CURTIS | VP, MEETINGS AND CORP. PAR | 39.00 |
Highest
|
$244,693 | $39,774 | $284,467 |
| ELIZABETH DURZY | VP, PUBL. AND PRACTICE RESOURCES | 39.00 |
Highest
|
$212,074 | $33,650 | $245,724 |
| STEVEN FOLSTEIN | VP OF EDUCATION AND PROF DVLPMNT | 43.00 |
Highest
|
$168,463 | $32,623 | $201,086 |
| CRYSTAL JONES | DIRECTOR, HUMAN RESOURCES | 35.00 |
Highest
|
$142,287 | $29,736 | $172,023 |
| LAURA SHELTERS | DIRECTOR, EDU., PROGRAM DESIGN, & EVALUATION | 35.00 |
Highest
|
$142,750 | $26,956 | $169,706 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $18,281,444 | $20,311,953 | $35,063,665 | $-2,030,509 |
| 2024 | $15,925,326 | $18,577,313 | $34,244,566 | $-2,651,987 |
| 2023 | $16,078,688 | $19,046,321 | $34,254,767 | $-2,967,633 |
| 2022 | $8,439,460 | $15,175,180 | $35,081,762 | $-6,735,720 |
| 2021 | $14,513,598 | $12,183,550 | $42,394,196 | $2,330,048 |
| 2020 | $14,665,136 | $16,032,765 | $35,678,711 | $-1,367,629 |
| 2019 | $15,226,783 | $16,893,325 | $36,780,872 | $-1,666,542 |
| 2018 | $15,189,144 | $15,607,184 | $38,760,970 | $-418,040 |
Compare AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES with other nonprofits in Virginia and across the country.